The purpose of this study is to test whether a ten-session behavioral intervention for HIV-infected injection drug users is effective in reducing sex and injection risk behaviors that put others at risk for HIV infection, increasing access to or utilization of HIV primary health care, and increasing adherence to HIV medications.

- lending needle or sharing cotton, cooker, or rinse water with HIV-negative or unknown serostatus partners in the past 3 months

-health care visits for HIV primary care in the past 6 months

-90% or more adherence to HIV medication yesterday and in the past week

Secondary Outcome Measures:

-Proportion of HIV status disclosure to sex partners

Estimated Enrollment:

1000

Study Start Date:

August 2001

Study Completion Date:

July 2006

Primary Completion Date:

July 2006 (Final data collection date for primary outcome measure)

Detailed Description:

INSPIRE is a four-site (Baltimore, Miami, New York and San Francisco) randomized control trial to develop and evaluate the efficacy of a ten-session intervention for HIV-positive injection drug users. The primary goals of the intervention are to:

not have participated in the full-pilot of this intervention and not have enrolled previously in the present study.

Exclusion Criteria:

-

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00146445